Vida Ventures Advisors, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 21, 2025), Vida Ventures Advisors, LLC reported 6 stock positions worth $146.3 million. Its top holding was Centessa Pharmaceuticals (CNTA) at 45.0% of the portfolio, followed by Tectonic Therapeutic (TECX, 32.5%) and Kyverna Therapeutics (KYTX, 11.6%). Its holdings were unchanged from Q3 2024.
- Most Recent 13F
- Q3 2025
- Location
- BOSTON, MA
- CIK
- 0001831423
- Portfolio Value
- $146.3M (Q4 2024)
- SEC Filing
- 0000950123-25-000395 ↗ filed Jan 21, 2025
Holdings Value
Holdings 6 stocks · $146.3M
| CNTA Centessa Pharmaceuticals Ltd. | 45.01% | 3,931,818 | $65.9M | No change |
| TECX Tectonic Therapeutic Inc. | 32.46% | 1,028,674 | $47.5M | No change |
| KYTX Kyverna Therapeutics Inc. | 11.56% | 4,523,924 | $16.9M | No change |
| DYN Dyne Therapeutics Inc. | 6.56% | 407,499 | $9.6M | No change |
| ALLO Allogene Therapeutics Inc. | 2.62% | 1,798,163 | $3.8M | No change |
| KRON Kronos Bio Inc. | 1.80% | 2,765,314 | $2.6M | No change |
Portfolio Sells Q3 2024 → Q4 2024
| None this quarter. | |||
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||